Prevalence and Treatment Patterns of Autism Spectrum Disorder in the United States, 2016

JAMA Pediatrics

Volumn 173, Issue 2, 2019, Pages 153-159

  Xu, Guifeng ^a,b   Strathearn, Lane ^b,c   Liu, Buyun ^a   O'Brien, Matthew ^b   Kopelman, Todd G ^c   Zhu, Jing ^a   Snetselaar, Linda G ^a   Bao, Wei ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

ADOLESCENT; ARTICLE; ASIAN; AUTISM; BEHAVIOR THERAPY; BLACK PERSON; CHILD; CHILD HEALTH CARE; CHILD HEALTH INSURANCE; CROSS-SECTIONAL STUDY; FEMALE; FLORIDA; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PUBLIC HEALTH INSURANCE; RACE DIFFERENCE; SEX DIFFERENCE; TEXAS; UNITED STATES; CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH SURVEY; MULTIMODALITY CANCER THERAPY; STATISTICAL MODEL;

ADOLESCENT; AUTISM SPECTRUM DISORDER; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; PRACTICE PATTERNS, PHYSICIANS'; PREVALENCE; UNITED STATES;

EID: 85057801803     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2018.4208     Document Type: Article

References (31)

1. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014; 383 (9920): 896-910. doi: 10.1016/S0140-6736(13)61539-1 24074734
2. Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses [published online March 17, 2017]. Mol Autism. doi: 10.1186/s13229-017-0121-4 28331572
3. Geschwind DH, State MW. Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 2015; 14 (11): 1109-1120. doi: 10.1016/S1474-4422(15)00044-7 25891009
4. Lyall K, Croen L, Daniels J, The changing epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017; 38: 81-102. doi: 10.1146/annurev-publhealth-031816-044318 28068486
5. Buescher AV, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr. 2014; 168 (8): 721-728. doi: 10.1001/jamapediatrics.2014.210 24911948
6. Christensen DL, Baio J, Van Naarden Braun K,; Centers for Disease Control and Prevention (CDC). Prevalence and characteristics of autism spectrum disorder among children aged 8 years: Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveill Summ. 2016; 65 (3): 1-23. doi: 10.15585/mmwr.ss6503a1 27031587
7. Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ. Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey. Natl Health Stat Report. 2015;(87): 1-20. 26632847
8. Blumberg SJ, Bramlett MD, Kogan MD, Schieve LA, Jones JR, Lu MC. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012. Natl Health Stat Report. 2013;(65): 1-11, 12. 24988818
9. Xu G, Strathearn L, Liu B, Bao W. Prevalence of autism spectrum disorder among US children and adolescents, 2014-2016. JAMA. 2018; 319 (1): 81-82. doi: 10.1001/jama.2017.17812 29297068
10. Ospina MB, Krebs Seida J, Clark B, Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review. PLoS One. 2008; 3 (11): e3755. doi: 10.1371/journal.pone.0003755 19015734
11. Weitlauf AS, McPheeters ML, Peters B, Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
12. Maglione MA, Gans D, Das L, Timbie J, Kasari C; Technical Expert Panel; HRSA Autism Intervention Research-Behavioral (AIR-B) Network. Nonmedical interventions for children with ASD: recommended guidelines and further research needs. Pediatrics. 2012; 130 (suppl 2): S169-S178. doi: 10.1542/peds.2012-0900O 23118248
13. Reichow B, Barton EE, Boyd BA, Hume K. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2012; 10: CD009260. 23076956
14. Pierce K, Courchesne E, Bacon E. To screen or not to screen universally for autism is not the question: why the Task Force got it wrong. J Pediatr. 2016; 176: 182-194. doi: 10.1016/j.jpeds.2016.06.004 27421956
15. Dawson G, Jones EJ, Merkle K, Early behavioral intervention is associated with normalized brain activity in young children with autism. J Am Acad Child Adolesc Psychiatry. 2012; 51 (11): 1150-1159. doi: 10.1016/j.jaac.2012.08.018 23101741
16. Pickles A, Le Couteur A, Leadbitter K, Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trial. Lancet. 2016; 388 (10059): 2501-2509. doi: 10.1016/S0140-6736(16)31229-6 27793431
17. Witwer A, Lecavalier L. Treatment incidence and patterns in children and adolescents with autism spectrum disorders. J Child Adolesc Psychopharmacol. 2005; 15 (4): 671-681. doi: 10.1089/cap.2005.15.671 16190798
18. Aman MG, Lam KS, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. J Autism Dev Disord. 2003; 33 (5): 527-534. doi: 10.1023/A:1025883612879 14594332
19. Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics. 2008; 121 (3): e441-e448. doi: 10.1542/peds.2007-0984 18310165
20. Data Resource Center for Child and Adolescent Health. NSCH survey methodology. http://www.childhealthdata.org/learn-about-the-nsch/methods. Accessed November 2, 2018.
21. Zablotsky B, Black LI, Blumberg SJ. Estimated prevalence of children with diagnosed developmental disabilities in the United States, 2014-2016. NCHS Data Brief. 2017;(291): 1-8. 29235982
22. Kogan MD, Blumberg SJ, Schieve LA, Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics. 2009; 124 (5): 1395-1403. doi: 10.1542/peds.2009-1522 19805460
23. Ali MM, Teich J, Lynch S, Mutter R. Utilization of mental health services by preschool-aged children with private insurance coverage. Adm Policy Ment Health. 2018; 45 (5): 731-740. doi: 10.1007/s10488-018-0858-x 29476292
24. Myers SM, Johnson CP; American Academy of Pediatrics Council on Children With Disabilities. Management of children with autism spectrum disorders. Pediatrics. 2007; 120 (5): 1162-1182. doi: 10.1542/peds.2007-2362 17967921
25. Orinstein AJ, Helt M, Troyb E, Intervention for optimal outcome in children and adolescents with a history of autism. J Dev Behav Pediatr. 2014; 35 (4): 247-256. doi: 10.1097/DBP.0000000000000037 24799263
26. Fein D, Barton M, Eigsti IM, Optimal outcome in individuals with a history of autism. J Child Psychol Psychiatry. 2013; 54 (2): 195-205. doi: 10.1111/jcpp.12037 23320807
27. Fountain C, Winter AS, Bearman PS. Six developmental trajectories characterize children with autism. Pediatrics. 2012; 129 (5): e1112-e1120. doi: 10.1542/peds.2011-1601 22473372
28. Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2015; 24 (1): 117-143. doi: 10.1016/j.chc.2014.09.004 25455579
29. Perrin JM, Coury DL, Hyman SL, Cole L, Reynolds AM, Clemons T. Complementary and alternative medicine use in a large pediatric autism sample. Pediatrics. 2012; 130 (suppl 2): S77-S82. doi: 10.1542/peds.2012-0900E 23118257
30. Salomone E, Charman T, McConachie H, Warreyn P; Working Group 4, COST Action 'Enhancing the Scientific Study of Early Autism.' Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe. Eur J Pediatr. 2015; 174 (10): 1277-1285. doi: 10.1007/s00431-015-2531-7 25855095
31. Höfer J, Hoffmann F, Bachmann C. Use of complementary and alternative medicine in children and adolescents with autism spectrum disorder: a systematic review. Autism. 2017; 21 (4): 387-402. doi: 10.1177/1362361316646559 27231337